Thomas Powers
Pfizer, Inc.
Thomas Powers is a senior scientist at Pfizer, working in the Analytical Research and Development group at the Chesterfield, MO location. Thomas obtained his BS in chemistry and BA in economics at Furman University in Greenville, SC. He then attended the Medical University of South Carolina in Charleston, SC, where he completed his Ph.D. under the guidance of Dr. Richard Drake. His dissertation research focused on developing methods for MALDI imaging of N-linked glycans and the discovery of glycan and glycoprotein disease markers for pancreatic cancer.
Thomas joined Pfizer two years ago and works in the Mass Spectrometry and Biophysical Characterization (MSBC) group, which is responsible for heightened product characterization and bioprocess support. Since joining Pfizer, he has developed a wide range of experiences working with multiple modalities, including mAbs, recombinant proteins, and ADCs. More recently, Thomas has been working to develop methodologies capable of analyzing viral vector capsid proteins, specifically those of adeno-associated virus and adenovirus. In addition to supporting several programs, Thomas is involved in the implementation of multi-attribute monitoring by mass spectrometry at Pfizer and in exploring new software to assist heightened characterization of Pfizer products.
Thomas joined Pfizer two years ago and works in the Mass Spectrometry and Biophysical Characterization (MSBC) group, which is responsible for heightened product characterization and bioprocess support. Since joining Pfizer, he has developed a wide range of experiences working with multiple modalities, including mAbs, recombinant proteins, and ADCs. More recently, Thomas has been working to develop methodologies capable of analyzing viral vector capsid proteins, specifically those of adeno-associated virus and adenovirus. In addition to supporting several programs, Thomas is involved in the implementation of multi-attribute monitoring by mass spectrometry at Pfizer and in exploring new software to assist heightened characterization of Pfizer products.